The authors summarize evolving strategies to target BCSCs, which have become a pivotal aspect of therapeutic development. They explore a variety of approaches, including targeting specific tumor surface markers, transporters, heat shock proteins, and critical signaling pathways like Notch, Akt, Hedgehog, KLF4, and Wnt/β-catenin.
[Medical Oncology]
